Protective effect of clusterin on blood-retinal barrier breakdown in diabetic retinopathy

Investigative Ophthalmology and Visual Science

Volumn 51, Issue 3, 2010, Pages 1659-1665

  Kim, Jeong Hun ^a   Kim, Jin Hyoung ^a   Yu, Young Suk ^a   Min, Bon Hong ^b   Kim, Kyu Won ^c  

^a Seoul National University Hospital   (South Korea)

^b Korea University College of Medicine   (South Korea)

^c Seoul National University   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ADVANCED GLYCATION END PRODUCT; CELL PROTEIN; CLUSTERIN; VASCULOTROPIN; MEMBRANE PROTEIN; PHOSPHOPROTEIN; PROTEIN ZO1; VASCULOTROPIN A; ZONULA OCCLUDENS-1 PROTEIN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD RETINA BARRIER; BLOOD VESSEL PERMEABILITY; CELL VIABILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; DIABETIC RETINOPATHY; DRUG MECHANISM; ENDOTHELIUM CELL; EYE TOXICITY; HUMAN; HUMAN CELL; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RETINA BLOOD VESSEL; STREPTOZOCIN DIABETES; TIGHT JUNCTION; VASCULAR ENDOTHELIUM; ANIMAL; C57BL MOUSE; CAPILLARY PERMEABILITY; CELL SURVIVAL; CULTURE TECHNIQUE; CYTOLOGY; DRUG EFFECT; EXPERIMENTAL DIABETES MELLITUS; IMMUNOHISTOCHEMISTRY; INJECTION; ISOLATION AND PURIFICATION; METABOLISM; NICK END LABELING; VITREOUS BODY; WESTERN BLOTTING;

ANIMALS; BLOOD-RETINAL BARRIER; BLOTTING, WESTERN; CAPILLARY PERMEABILITY; CELL CULTURE TECHNIQUES; CELL SURVIVAL; CLUSTERIN; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC RETINOPATHY; ENDOTHELIUM, VASCULAR; GLYCOSYLATION END PRODUCTS, ADVANCED; IMMUNOHISTOCHEMISTRY; IN SITU NICK-END LABELING; INJECTIONS; MEMBRANE PROTEINS; MICE; MICE, INBRED C57BL; PHOSPHOPROTEINS; RETINAL VESSELS; VASCULAR ENDOTHELIAL GROWTH FACTOR A; VITREOUS BODY;

EID: 77949893843     PISSN: 01460404     EISSN: 15525783     Source Type: Journal    
DOI: 10.1167/iovs.09-3615     Document Type: Article

References (26)

1. Porta M, Bandello F. Diabetic retinopathy: an update. Diabetologia. 2002;45:1617-1634.
2. Frank RN. Diabetic retinopathy. N Engl J Med. 2004;350:48-58.
3. Lorenzi M, Gerhardinger C. Early cellular and molecular changes induced by diabetes in the retina. Diabetologia. 2001; 44:791-804.
4. Antonetti DA, Barber AJ, Bronson SK, et al. Diabetic retinopathy: seeing beyond glucose-induced microvascular disease. Diabetes. 2006;55:2401-2411.
5. Lee SW, Kim WJ, Choi YK, et al. SSeCKS regulates angiogenesis and tight junction formation in blood-brain barrier. Nat Med. 2003;9:900-906.
6. Choi YK, Kim JH, Kim WJ, et al. AKAP12 regulates human bloodretinal barrier formation by downregulation of hypoxia-inducible factor-1alpha. J Neurosci. 2007;27:4472-4481.
7. Kim JH, Kim JH, Park JA, et al. Blood-neural barrier: intercellular communication at glio-vascular interface. J Biochem Mol Biol. 2006;39:339-345.
8. Kim JH, Kim JH, Yu YS, Min BH, Kim KW. The role of clusterin in retinal development and free radical damage. Br J Ophthalmol. 2007;91:1541-1546.
9. Kim JH, Yu YS, Kim JH, Kim KW, Min BH. The role of clusterin in in vitro ischemia of human retinal endothelial cells. Curr Eye Res. 2007;32:693-698.
10. Kim JH, Kim JH, Yu YS, Kim DH, Kim KW. The recruitment of pericytes and astrocytes is closely related to the formation of tight junction in developing retinal vessels. J Neurosci Res. 2009;87: 653-659.
11. Russ PK, Davidson MK, Hoffman LH, Haselton FR. Partial characterization of the human retinal endothelial cell tight and adherens junction complexes. Invest Ophthalmol Vis Sci. 1998;39:2479-2485.
12. Blaschuk O, Burdzy K, Fritz IB. Purification and characterization of a cell-aggregating factor (clusterin), the major glycoprotein in ram rete testis fluid. J Biol Chem. 1983;258:7714-7720.
13. Poon S, Easterbrook-Smith SB, Rybchyn MS, Carver JA, Wilson MR. Clusterin is an ATP-independent chaperone with very broad substrate specificity that stabilizes stressed proteins in a folding competent state. Biochemistry. 2000;39:15953-15960.
14. Wilson MR, Easterbrook-Smith SB. Clusterin is a secreted mammalian chaperone. Trends Biochem Sci. 2000;25:95-98.
15. Shin YJ, Kang SW, Jeong SY, et al. Clusterin enhances proliferation of primary astrocytes through extracellular signal-regulated kinase activation. Neuroreport. 2006;17:1871-1875.
16. Kim JH, Kim JH, Yu YS, Cho CS, Kim KW. Blockade of angiotensin II attenuates VEGF-mediated blood-retinal barrier breakdown in diabetic retinopathy. J Cereb Blood Flow Metab. 2009;29:621-628.
17. Kim JH, Kim JH, Lee YM, et al. Decursin inhibits VEGF-mediated inner blood-retinal barrier breakdown by suppression of VEGFR-2 activation. J Cereb Blood Flow Metab. 2009;29:1559-1567.
18. Min JK, Cho YL, Choi JH, et al. Receptor activator of nuclear factor (NF)-kappaB ligand (RANKL) increases vascular permeability: impaired permeability and angiogenesis in eNOS-deficient mice. Blood. 2007;109:1495-1502.
19. Min JK, Lee YM, Kim JH, et al. Hepatocyte growth factor suppresses vascular endothelial growth factor-induced expression of endothelial ICAM-1 and VCAM-1 by inhibiting the nuclear factorkappaB pathway. Circ Res. 2005;96:300-307.
20. Jones SE, Jomary C. Clusterin. Int J Biochem Cell Biol. 2002;34: 427-431.
21. Jenne DE, Tschopp J. Clusterin: the intriguing guises of a widely expressed glycoprotein. Trends Biochem Sci. 2002;17:154-159.
22. Gwon JS, Kim IB, Lee MY, Oh SJ, Chun MH. Expression of clusterin in Mueller cells of the rat retina after pressure-induced ischemia. Glia. 2004;47:35-45.
23. Bell RD, Sagare AP, Friedman AE, et al. Transport pathways for clearance of human Alzheimer's amyloid beta-peptide and apolipoproteins E and J in the mouse central nervous system. J Cereb Blood Flow Metab. 2007;27:909-918.
24. Sakakibara A, Furuse M, Saitou M, Ando-Akatsuka Y, Tsukita S. Possible involvement of phosphorylation of occludin in tight junction formation. J Cell Biol. 1997;137:1393-1401.
25. Fischer S, Wobben M, Marti HH, Renz D, Schaper W. Hypoxia-Induced hyperpermeability in brain microvessel endothelial cells involves VEGF-mediated changes in the expression of zonula occludens-1. Microvasc Res. 2002;63:70-80.
26. Harhaj NS, Felinski EA, Wolpert EB, Sundstrom JM, Gardner TW, Antonetti DA. VEGF activation of protein kinase C stimulates occludin phosphorylation and contributes to endothelial permeability. Invest Ophthalmol Vis Sci. 2006;47:5106-5115.